Suchergebnisse - "Stepień, A"

PubPharm (123)

1

Risk factor profile of different clinical manifestations of cerebral small vessel disease - data from SHEF-CSVD Study

enthalten in: bioRxiv.org | 2019

von Staszewski, J. | Skrobowska, E. | Piusińska-Macoch, R. | +2

2

The mean platelet volume on admission predicts unfavorable stroke outcomes in patients treated with IV thrombolysis

in: Clinical Interventions in Aging | 2019

von Staszewski J | Pogoda A | Data K | +4

3

IL-6, PF-4, sCD40 L, and homocysteine are associated with the radiological progression of cerebral small-vessel disease: a 2-year follow-up study

in: Clinical Interventions in Aging | 2018

von Staszewski J | Piusińska-Macoch R | Brodacki B | +2

4

An immediate effect of PNF specific mobilization on the angle of trunk rotation and the Trunk-Pelvis-Hip Angle range of motion in adolescent girls with double idiopathic scoliosis—a pilot study

enthalten in: Scoliosis | 2017

von Stępień, A. | Fabian, K. | Graff, K. | +2

5

An immediate effect of PNF specific mobilization on the angle of trunk rotation and the Trunk-Pelvis-Hip Angle range of motion in adolescent girls with double idiopathic scoliosis-a pilot study

enthalten in: Scoliosis and spinal disorders | 2017

von Stępień, A. | Fabian, K. | Graff, K. | +2

6

The most important psychological and psychosocial needs of Polish multiple sclerosis patients and their significant others

in: Neuropsychiatric Disease and Treatment | 2017

von Potemkowski A | Brola W | Ratajczak A | +9

7

Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa

enthalten in: Hypertension (Dallas, Tex. : 1979) | 2015

von Biaggioni, I. | Freeman, R. | Mathias, C. | +65

CommentIn: Hypertension. 2015 Jan;65(1):34-5. - PMID 25350983

8

Obesity indices and inflammatory markers in obese non-diabetic normo- And hypertensive patients. a comparative pilot study

enthalten in: Atherosclerosis | 2014

von Stepien, M. | Stepien, A. | Wlazel, R. | +3

9

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER) : a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Neurology | 2014

von Confavreux, C. | O'Connor, P. | Comi, G. | +110

CommentIn: Lancet Neurol. 2014 Mar;13(3):234-5. - PMID 24461573

10

Results of Membrane-Activated Chelator Stroke Intervention randomized trial of DP-b99 in acute ischemic stroke

enthalten in: Stroke | 2013

von Lees, K. | Bornstein, N. | Diener, H. | +104

ErratumIn: Stroke. 2013 Mar;44(3) :e23

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]